Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

MYGNMYGN
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in MYRIAD GENETICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.4M shares of MYGN (MYRIAD GENETICS INC), worth $13.8M as of 2026-Q2. The position was increased (+4.2% shares). MYGN represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$13.8M

Current Shares

2.4M

Total Value Change

-$45.2M

Total Shares Change

+262,162

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+4.2%
$13.8M0.0%$5.71
29
2026-Q1
Increased
2.3M
+4.0%
$10.4M0.0%$5.29
29
2025-Q4
Increased
2.2M
+0.3%
$13.7M0.0%$6.17
28
2025-Q3
Increased
2.2M
+0.1%
$16.1M0.0%$7.24
28
2025-Q2
Decreased
2.2M
-0.3%
$11.8M0.0%$5.25
0
2025-Q1
Increased
2.2M
+4.1%
$19.8M0.0%$8.88
30
2024-Q4
Decreased
2.1M
-0.5%
$29.4M0.0%$13.63
0
2024-Q3
Increased
2.2M
+1.0%
$59M0.0%$26.46
30

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used